Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Host transcriptional responses to gut microbiome variation arising from urbanism
Sabrina Arif, Shreya Nirmalan, Adnan Alazizi, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Cancer Research
|
November 28, 2019
Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
The Oncologist
|
September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
Ioannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Industrialization drives convergent microbial and physiological shifts in the human metaorganism
Mathilde Poyet, Malte Rühlemann, Ana P Schaan, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Host transcriptional responses to gut microbiome variation arising from urbanism
Sabrina Arif, Shreya Nirmalan, Adnan Alazizi, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Cancer Research
|
November 28, 2019
Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Mark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
The Oncologist
|
September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
Ioannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Industrialization drives convergent microbial and physiological shifts in the human metaorganism
Mathilde Poyet, Malte Rühlemann, Ana P Schaan, et al.
Page
of 4